Topical and Transdermal Delivery of L-Carnitine

被引:10
|
作者
Fox, L. T. [1 ]
Gerber, M. [1 ]
du Preez, J. L. [1 ]
Grobler, A. [1 ]
du Plessis, J. [1 ]
机构
[1] North West Univ, Unit Drug Res & Dev, ZA-2520 Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
L-Carnitine L-tartrate; Pheroid (TM); Skin aging; Topical delivery; SKIN; DIFFERENTIATION; KERATINOCYTES; PENETRATION; TRANSPORTER; SENESCENCE; ACID;
D O I
10.1159/000330385
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The two types of skin aging (intrinsic and extrinsic) share important molecular features, while having distinct differences on the macromolecular level: both lead to increased production of reactive oxygen species, enhanced matrix metalloproteinase expression and decreased procollagen synthesis. L-Carnitine L-tartrate has been reported to have anti-aging effects. Aim and Methods: The delivery as well as the transport of L-carnitine to the target sites, i.e. stratum corneum and epidermis-dermis of female abdominal skin, with and without the use of Pheroid (TM) as delivery system, were investigated during this study by use of Franz diffusion cells and analysed by liquid chromatography/mass spectrometry. The presence of endogenous L-carnitine in human skin was also investigated. Results and Conclusion: The Pheroid (TM) delivery system enhanced the diffusion of L-carnitine through the skin, although the phosphate buffer solution (PBS) showed a higher concentration of the active agent in the skin layers. This could be because Pheroid, being more lipophilic than PBS, improved the diffusion of L-carnitine through the skin layers, consequently leading to a lesser amount of L-carnitine delivered to the target site, i.e. the epidermis-dermis. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:330 / 336
页数:7
相关论文
共 50 条
  • [41] L-CARNITINE, INFLAMMATION AND HYPERTENSION
    Davis, Paul A.
    Mormino, Paolo
    Savica, Vincenzo
    Calo, Lorenzo A.
    [J]. NEPHROLOGY, 2009, 14 (02) : 264 - 265
  • [42] L-carnitine treatment of anemia
    Golper, TA
    Goral, S
    Becker, BN
    Langman, CB
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : S27 - S34
  • [43] L-Carnitine in Drosophila: A Review
    Carillo, Maria Rosaria
    Bertapelle, Carla
    Scialo, Filippo
    Siervo, Mario
    Spagnuolo, Gianrico
    Simeone, Michele
    Peluso, Gianfranco
    Digilio, Filomena Anna
    [J]. ANTIOXIDANTS, 2020, 9 (12) : 1 - 19
  • [44] L-CARNITINE AND INTESTINAL INFLAMMATION
    Fortin, Genevieve
    [J]. VITAMINS AND THE IMMUNE SYSTEM, 2011, 86 : 353 - 366
  • [45] Antihypertensive effect of L-carnitine
    Monserrat, M. T.
    Miguel-Carrasco, J. L.
    Mate, A.
    Arias, J. L.
    Aramburu, O.
    Vazquez, C. M.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 : S254 - S254
  • [46] Topical and transdermal delivery of caffeine
    Luo, Lin
    Lane, Majella E.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 490 (1-2) : 155 - 164
  • [47] Production and characterization of monoclonal antibodies against L-carnitine: Radioimmunologic assays for L-carnitine determination
    Marini, S
    Fasciglione, GF
    Giardina, B
    [J]. CLINICA CHIMICA ACTA, 1996, 249 (1-2) : 93 - 108
  • [48] L-CARNITINE THERAPY FOR MUSCLE TYPE CARNITINE DEFICIENCY
    OHTANI, Y
    MIIKE, T
    OHHIRA, T
    MATSUDA, I
    [J]. BRAIN & DEVELOPMENT, 1986, 8 (02): : 226 - 226
  • [49] RENAL REABSORPTION OF L-CARNITINE IN PATIENTS WITH CARNITINE DEFICIENCY
    BERTOLI, M
    REBESCHINI, M
    RUFFATTI, A
    ROMAGNOLI, GF
    FREDDO, L
    VERGANI, L
    ANGELINI, C
    DILANDRO, D
    [J]. KIDNEY INTERNATIONAL, 1984, 26 (04) : 488 - 488
  • [50] TRANSINTESTINAL TRANSPORT OF L-CARNITINE AND CARNITINE ESTERS IN THE RAT
    MARCIANI, P
    LINDI, C
    MARZO, A
    MARTELLI, EA
    CARDACE, G
    ESPOSITO, G
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1989, 415 (03): : S9 - S9